The Trade Alliance to Promote Prosperity has written a letter to members of the U.S. House of Representatives, urging them to protect intellectual property and oppose H.R. 2873, the “Affordable Prescriptions for Patients Act through Promoting Competition Act of 2021,” which would aid and abet Federal Trade Commission attacks on American businesses and grant FTC Chair Lina Kahn unprecedented power for an unelected bureaucrat. The bill is sponsored by Rep. David Cicilline (D – Rhode Island) and cosponsored by Reps. Ken Buck (R – Colorado), Carolyn Maloney (D – New York), and Jerrold Nadler (D – New York), and Del. Eleanor Holmes Norton (D – District of Columbia).
Read MoreLast year, 15 countries formed what is now the world’s largest trading bloc. The United States is not part of it. The Regional Comprehensive Economic Partnership (RCEP) comprises Australia, Brunei, Cambodia, China, Indonesia, Japan, Laos, Malaysia, Myanmar, New Zealand, the Philippines, Singapore, South Korea, Thailand, and Vietnam.
Read MoreAnyone hoping that the Biden administration would pursue international trade policies to counter the protectionism of the Trump administration should be sorely disappointed…
Read MoreThe Cornyn-Blumenthal Bill would effectively empower the FTC to oversee American prescription drug innovation and development and grant them the ability to quash drug innovations. If passed, this legislation would come at the peril of American patients awaiting innovations to address their serious suffering from medical conditions and diseases that could otherwise be treated or cured.
Read MoreThe Trade Alliance to Promote Prosperity and 70 organizations have written a letter to members of Congress, urging them to oppose H.R. 3.
Read MoreOn April 22, U.S. House of Representatives Energy and Commerce Committee Chairman Frank Pallone Jr. (D-NJ), Ways and Means Committee Chairman Richard E. Neal (D-MA), and Education and Labor Committee Chairman Robert C. "Bobby" Scott (D-VA) reintroduced H.R. 3, a terrible piece of legislation known as the “Lower Drug Costs Now Act,” which, for good reasons, failed to be passed into law in the last session of Congress.
Read MoreSeveral years ago, LG Chem, now LG Energy Solution, a subsidiary of a rival South Korean global conglomerate, accused SKI of stealing trade secrets from LG’s lithium-ion battery technology and then leveraging them to secure lucrative contracts with Ford and Volkswagen.
Read MoreIn a recent interview with the New York Times, Bill Gates articulated the importance of maintaining intellectual property protection in the face of the COVID-19 pandemic.
Read MoreIn the quest to attract investment from foreign and domestic corporations, the State of Georgia has become a home for Electric Vehicle-related manufacturing. In 2019, SK Innovation (SKI), an Electric Vehicle (EV) battery manufacturer and subsidiary of a South Korean global conglomerate, broke ground in the town of Commerce, Georgia, on a $1.67 billion manufacturing plant to produce batteries for Ford and Volkswagen, with a promise of creating 2,000 jobs.
Read MoreIn the quest to attract investment from foreign and domestic corporations, the State of Georgia has become a home for Electric Vehicle-related manufacturing. In 2019, SK Innovation (SKI), an Electric Vehicle (EV) battery manufacturer and subsidiary of a South Korean global conglomerate, broke ground in the town of Commerce, Georgia, on a $1.67 billion manufacturing plant to produce batteries for Ford and Volkswagen, with a promise of creating 2,000 jobs.
Read MoreU.S. Representative Jan Schakowsky of Illinois has drafted a letter asking the Biden administration to reverse the Trump administration’s opposition to removing intellectual property protections relevant to COVID-19 medicines. In a nutshell, Schakowsky’s idea is to allow the infringement of longstanding intellectual property rights to let developing countries produce medicines outside the normal operating parameters.
Read MoreGlobal battery manufacturer LG Chem’s battery spinoff is known as LG Energy Solution. In partnership with General Motors, it has established a sizable footprint in Ohio. In 2019, LG announced plans to construct a facility in Northeast Ohio as part of a $2.3 billion investment that is expected to generate well over 1,000 new local jobs.
Read MoreThe Trade Alliance to Promote Prosperity is pleased to join 75+ national and state-based free market organizations in opposing the "Most Favored Nation" Model that would import socialist price controls and inject them into American healthcare.
Read MoreRight now, two subsidiaries of Korean global conglomerates are engaged in a bitter intellectual property (IP) theft dispute before the United States International Trade Commission (ITC). LG Chem has accused SK Innovation of stealing trade secrets pertaining to its lithium-ion battery technology and then leveraging these trade secrets to secure lucrative contracts in the United States,... read more.
Read MoreFrom Georgetown Capital Advisors: On June 26, The Mosaic Company (NYSE: MOS) announced that it had filed petitions with the US International Trade Commission (ITC) and the US Department of Commerce (DoC) requesting the imposition of countervailing duties (CVDs) on imports of phosphate from Morocco and Russia. Mosaic’s stock has, since that date, appreciated 80.5% as of the market close on Friday, December 11, with price increases following key events related to the investigation.
Read MoreUS Patent and Trademark Office (USPTO) Director Andrei Iancu put out a request for comments for feedback on what stakeholders think the rules should be for the Patent Trial & Appeal Board (PTAB). This represented a pivotal opportunity to commend the USPTO for this inquiry and urge serious regulations/guardrails/reforms to PTAB--an opportunity we gladly seized. Read the comments we submitted here.
Read MoreThe bottom line: Socialist price controls are harmful to patients and harmful to the American economy.
Read MoreThe Trade Alliance to Promote Prosperity, along with 22 other free market groups, recently signed onto a letter to U.S. Senator Lindsey Graham, Chairman of the Senate Judiciary Committee, and U.S. Representative Jim Jordan, Ranking Member of the House Judiciary Committee, expressing our strong support for the important changes that the current leadership of the U.S. Patent & Trademark Office (USPTO) has made over the past three years to bolster patent reliability and to promote the rule of law.
Read MoreThe Trade Alliance to Promote Prosperity recently signed onto a letter in response to a request for comments from U.S. Senator Lamar Alexander and U.S. Representative Greg Walden regarding modernization of the 340B drug pricing program.
Read MoreOn September 24, the Trump administration finalized its plan to allow for the importation of prescription drugs from foreign markets. Under the plan, states could develop proposals for federal government approval to facilitate the importation of certain drugs from Canada.
Read More